BackBrainstorm Cell Therapeutics Overview

Brainstorm Cell Therapeutics Long-Term Investments

Track Brainstorm Cell Therapeutics's long-term investments ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long-Term Investments
$0.00

Peer average / median

Loading

Brainstorm Cell Therapeutics Long-Term Investments History

Loading

Brainstorm Cell Therapeutics vs. peers: Long-Term Investments Comparison

Loading

Brainstorm Cell Therapeutics Long-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Brainstorm Cell Therapeutics (BCLI) FAQ

The latest long-term investments for BCLI is $0 as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Brainstorm Cell Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, BCLI's long-term investments moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Brainstorm Cell Therapeutics's operating scale or balance-sheet position.

A long-term investments figure of $0 for BCLI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BCLI's long-term investments ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Brainstorm Cell Therapeutics's long-term investments against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.